Liraglutide, a GLP-1 Receptor Agonist, Mitigates LPS-Induced Osteoclastogenesis and Bone Loss by Downregulating Macrophage TNF-α Expression.
Saved in:
| Title: | Liraglutide, a GLP-1 Receptor Agonist, Mitigates LPS-Induced Osteoclastogenesis and Bone Loss by Downregulating Macrophage TNF-α Expression. |
|---|---|
| Authors: | Murakami, Kou1 (AUTHOR), Kitaura, Hideki1,2 (AUTHOR) hideki.kitaura.b4@tohoku.ac.jp, Ohori, Fumitoshi1,3 (AUTHOR), Marahleh, Aseel2,4 (AUTHOR), Lin, Angyi1 (AUTHOR), Fan, Ziqiu1,2 (AUTHOR), Narita, Kohei1,3 (AUTHOR), Ishiyama, Tomoko1,4 (AUTHOR), Hu, Jin1 (AUTHOR), Zheng, Huidan1 (AUTHOR), Kanetaka, Hiroyasu1,3,4 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5624. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms27125624 |